Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Kiniksa Pharmaceuticals International, plc (KNSA), most recent 12 months reported: revenue $754.04M, net income $73.06M, free cash flow $164.23M. Latest balance sheet on file: liquid cash $468.09M. From SEC filings. More on Kiniksa Pharmaceuticals International, plc: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: Collegium Pharmaceutical, Inc. · TG THERAPEUTICS, INC. · AXSOME THERAPEUTICS, INC. · EMERGENT BIOSOLUTIONS INC. · PACIRA BIOSCIENCES, INC. · Amphastar Pharmaceuticals, Inc. · ULTRAGENYX PHARMACEUTICAL INC. · BridgeBio Pharma, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.